Skip to main content

Clinical and Translational Science Collaborative

Ten CTSAs collaborate to assess Scientific Review Committee feasibility and impact, publish manuscript on findings
Scientific quality and feasibility are part of ethics review by Institutional Review Boards (IRBs). Scientific Review Committees (SRCs) were proposed to facilitate this assessment by the Clinical and Translational Science Award (CTSA) SRC Consensus Group. This study assessed SRC feasibility and…
GettyImages-838337078
Apply for a collaborative working retreat
The Community & Collaboration Component of the Clinical and Translational Science Collaborative (CTSC) offers four-hour professionally facilitated work sessions for established or emerging interdisciplinary groups of investigators with engaged stakeholders that need time to brainstorm and…
GettyImages-838337078
Clinical and Translational Science Collaborative’s Community and Collaboration Component selects teams for pilot awards
The Community and Collaboration Component (C&C) of the Clinical and Translational Science Collaborative (CTSC) selected two collaborative teams to receive the first round of pilot awards focused on team science with stakeholder engagement. Recipients needed to demonstrate they were an…
Real-world evidence from interdisciplinary teams: The Cleveland Institute for Computational Biology and The Book of OHDSI
The Cleveland Institute for Computational Biology (CICB) is pleased to announce that it has been instrumental in helping to create The Book of OHDSI, 1 st Edition , the first textbook describing the Observational Health Data Sciences and Informatics (OHDSI) community, the OHDSI (OMOP) data…
KL2 Scholar alum receives $7.2 million NIH grant to study transmission of tuberculosis in Uganda
Charles Bark, MD, CTSC KL2 Scholar alum and an infectious disease specialist in the MetroHealth Medical Center Department of Medicine, was awarded a 5-year $7.2 million NIH grant to study patterns of tuberculosis (TB) transmission in Kampala, Uganda. Decreasing the global burden of TB requires…
Daniel%20Ontaneda.jpg
Interview with a KL2 Scholar alum: Exploring early multiple sclerosis treatment strategies
When it comes to initial treatment selection for relapsing-remitting multiple sclerosis (RRMS), there is one question that has yet to be answered: Is it better to start with potentially safer moderately effective disease-modifying treatments (DMTs) or to hit the disease immediately with a…
CTSC Regulatory Steering Group convened to promote city-wide interaction and collaboration
Faculty, staff members, and invited guests supporting research administration from all four of our partner institutions convened on Wednesday, August 14, 2019 for the CTSC Regulatory Steering Group Meeting. This gathering of over 20 individuals from Case Western Reserve University, the Cleveland…
KL2 alum helps shed light on vitamin D supplementation and prevention of type 2 diabetes
Sangeeta Kashyap, MD, Department of Endocrinology, Diabetes and Metabolism at the Cleveland Clinic, and CTSC KL2 scholar alum, was part of a large, multi-institution study to determine whether vitamin D supplementation lowers the risk of type 2 diabetes. Their results have been published in the New…
Risk-period-cohort method has broad implications for examining processes of change over time in longitudinal studies
In epidemiology, gerontology, human development and the social sciences, age-period-cohort (APC) models are used to study the variability in trajectories of change over time. A well-known issue exists in simultaneously identifying age, period and birth cohort effects, namely that the three…
AI framework can inform radiation therapy dosage using patient medical scans
In a new paper published in Lancet Digital Health, recent CTSC KL2 Scholar grad and radiation oncologist at the Cleveland Clinic, Dr. Mohamed Abazeed and colleagues show that an artificial intelligence (AI) framework can provide personalized radiation dosage based on data from CT scans and…